Condition
Hashimotos Thyroiditis
Total Trials
6
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Unknown1
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06603415Not ApplicableRecruitingPrimary
Hashimoto's Thyroiditis in Upper Egypt
NCT06521359Not Yet RecruitingPrimary
Role of Follicular T Cells in Hashimoto's Thyroiditis
NCT02190214Completed
Thyroid Disorders in Malaysia: A Nationwide Multicentre Study
NCT02126683Not ApplicableUnknownPrimary
The Effect of Plaquenil on Serum Inflammatory Markers and Goiter in Euthyroid Young Women With Hashimoto's Thyroiditis
NCT01428167Completed
Hashimotos Thyroiditis and Thyroid Cancer
NCT00271427Not ApplicableCompleted
Selenium Treatment in Autoimmune Thyroiditis (AIT)
Showing all 6 trials